(Q33479305)

27 July 2017

title

A phase II study of cis-diamminedichloroplatinum and 5-fluorouracil in advanced upper aerodigestive neoplasms (English)

1 reference

27 July 2017

1 reference

2

Ingle JN

1 reference

27 July 2017

Creagan ET

1

1 reference

27 July 2017

Schutt AJ

series ordinal

3

1 reference

27 July 2017

O'Fallon JR

series ordinal

4

1 reference

27 July 2017

publication date

1 July 1984

1 reference

27 July 2017

1 reference

27 July 2017

volume

6

1 reference

27 July 2017

issue

6

1 reference

27 July 2017

page(s)

1020-1023

1 reference

Chemotherapy for advanced and recurrent squamous cell carcinoma of the head and neck with high and low dose cis-diamminedichloroplatinum

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890060607

7 January 2021

24-hour infusion of cis-platinum in head and neck cancers

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890060607

7 January 2021

Chemotherapy prior to local therapy in advanced squamous cell carcinoma of the head and neck: Preliminary assessment of an intensive drug regimen

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890060607

7 January 2021

Cyclophosphamide, adriamycin, and cis-diamminedichloroplatinum (II) in the treatment of patients with advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890060607

7 January 2021

Chemotherapy for squamous cell carcinoma of the head and neck: A progress report

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890060607

7 January 2021

cis-platinum and 5-fluorouracil as initial therapy in advanced epidermoid cancers of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890060607

7 January 2021

Cis-platinum and 5-fluorouracil as induction therapy for advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890060607

7 January 2021

Evaluation of response criteria in advanced lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890060607

7 January 2021

Chemotherapy of advanced head and neck cancer with methotrexate, bleomycin, and cis-diamminedichloroplatinum II in an effective outpatient schedule

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890060607

7 January 2021

Combination therapy of advanced head and neck cancer: induction of remissions with diamminedichloroplatinum (II), bleomycin and radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890060607

7 January 2021

Induction chemotherapy in advanced squamous head and neck carcinoma with high-dose cis-platinum and bleomycin infusion

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890060607

7 January 2021

Identifiers

DOI

10.1002/HED.2890060607

1 reference

27 July 2017

1 reference